Literature DB >> 8810255

RAG mutations in human B cell-negative SCID.

K Schwarz1, G H Gauss, L Ludwig, U Pannicke, Z Li, D Lindner, W Friedrich, R A Seger, T E Hansen-Hagge, S Desiderio, M R Lieber, C R Bartram.   

Abstract

Patients with human severe combined immunodeficiency (SCID) can be divided into those with B lymphocytes (B+ SCID) and those without (B- SCID). Although several genetic causes are known for B+ SCID, the etiology of B- SCID has not been defined. Six of 14 B- SCID patients tested were found to carry a mutation of the recombinase activating gene 1 (RAG-1), RAG-2, or both. This mutation resulted in a functional inability to form antigen receptors through genetic recombination and links a defect in one of the site-specific recombination systems to a human disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8810255     DOI: 10.1126/science.274.5284.97

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  151 in total

Review 1.  Severe combined immunodeficiency--molecular pathogenesis and diagnosis.

Authors:  H B Gaspar; K C Gilmour; A M Jones
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

Review 2.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 3.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

4.  Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinase.

Authors:  Leslie E Huye; Mary M Purugganan; Ming-Ming Jiang; David B Roth
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 5.  Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.

Authors:  Fabio Candotti; Luigi Notarangelo; Roberta Visconti; John O'Shea
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

6.  Rag-1 mutations associated with B-cell-negative scid dissociate the nicking and transesterification steps of V(D)J recombination.

Authors:  W Li; F C Chang; S Desiderio
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 7.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

8.  Functional and biochemical dissection of the structure-specific nuclease ARTEMIS.

Authors:  Ulrich Pannicke; Yunmei Ma; Karl-Peter Hopfner; Doris Niewolik; Michael R Lieber; Klaus Schwarz
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

9.  The multiple causes of human SCID.

Authors:  Rebecca H Buckley
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

10.  A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.

Authors:  Mirjam van der Burg; Hanna Ijspeert; Nicole S Verkaik; Tuba Turul; Wouter W Wiegant; Keiko Morotomi-Yano; Pierre-Olivier Mari; Ilhan Tezcan; David J Chen; Malgorzata Z Zdzienicka; Jacques J M van Dongen; Dik C van Gent
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.